Coloplast A/S 2022 AR2
The report highlights Coloplast's performance and strategic progress for the fiscal year 2021/22, including the key acquisition of Atos Medical to expand into voice and respiratory care. The company achieved 6% organic revenue growth and an EBIT margin of 31% before special items. In sustainability, Coloplast's science-based carbon reduction targets were approved by the Science Based Targets initiative (SBTi), aligning with a 1.5°C pathway. The company increased its renewable energy share to 72% and improved its production waste recycling rate to 71%.
Company: Coloplast A/S
Sector: Manufacturing
Country: Denmark
Year: 2022
Type: AR2
Pages: 136
Back to company
Coloplast A/S
Annual Report
The report highlights Coloplast's performance and strategic progress for the fiscal year 2021/22, including the key acquisition of Atos Medical to expand into voice and respiratory care. The company achieved 6% organic revenue growth and an EBIT margin of 31% before special items. In sustainability, Coloplast's science-based carbon reduction targets were approved by the Science Based Targets initiative (SBTi), aligning with a 1.5°C pathway. The company increased its renewable energy share to 72% and improved its production waste recycling rate to 71%.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Oct 1, 2021 - Sep 30, 2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Renewable Energy
Women in Management
Employees